Abstract
Radiochemotherapy (RCT) is an effective standard therapy for locally advanced head and neck squamous cell carcinoma (LA-HNSCC). Nonetheless, toxicity is common, with patients often requiring dose modifications. To investigate associations of RCT toxicities according to CTCAE version 5.0 and subsequent therapy modifications with short- and long-term treatment outcomes, we studied all 193 patients with HNSCC who received RCT (70 Gy + platinum agent) at an academic center between 03/2010 and 04/2018. During RCT, 77 (41%, 95% CI 34-49) patients developed at least one ≥ grade 3 toxicity, including seven grade 4 and 3 fatal grade 5 toxicities. The most frequent any-grade toxicities were xerostomia (n = 187), stomatitis (n = 181), dermatitis (n = 174), and leucopenia (n = 98). Eleven patients (6%) had their radiotherapy schedule modified (mean radiotherapy dose reduction = 12 Gy), and 120 patients (64%) had chemotherapy modifications (permanent discontinuation: n = 67, pause: n = 34, dose reduction: n = 7, change to other chemotherapy: n = 10). Objective response rates to RCT were 55% and 88% in patients with and without radiotherapy modifications (p = 0.003), and 84% and 88% in patients with and without chemotherapy modifications (p ...Continue Reading
References
May 18, 2004·International Journal of Radiation Oncology, Biology, Physics·Maria Grazia GhiGuglielmo Fila
Oct 26, 2007·The New England Journal of Medicine·Jan B VermorkenUNKNOWN EORTC 24971/TAX 323 Study Group
Oct 26, 2007·The New England Journal of Medicine·Marshall R PosnerUNKNOWN TAX 324 Study Group
Oct 22, 2008·Journal of Biomedical Informatics·Paul A HarrisJose G Conde
May 31, 2011·International Journal of Radiation Oncology, Biology, Physics·Robin J PrestwichMehmet Şen
Mar 19, 2013·World Journal of Surgical Oncology·Jie MaLai-ping Zhong
Jul 4, 2013·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·J O BrömmeD M Aebersold
Nov 22, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R HittUNKNOWN Spanish Head and Neck Cancer Cooperative Group (TTCC)
Jul 8, 2014·Expert Review of Anticancer Therapy·Tobenna Nwizu, David J Adelstein
Jul 23, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ezra E W CohenEverett E Vokes
Oct 1, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Gemma GattaUNKNOWN EUROCARE Working Group:
Sep 27, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Anna SpreaficoJohn Kim
Jan 14, 2017·Clinical Orthopaedics and Related Research·Florian PoschJoanna Szkandera
Apr 8, 2017·Medical Oncology·Pierfrancesco FrancoUmberto Ricardi
Jul 30, 2017·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·A Al-MamganiM E Tesselaar
Sep 25, 2017·Oral Oncology·Michael BaineApar Ganti
Dec 9, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Vanita NoronhaKumar Prabhash
Jan 8, 2018·International Journal of Cardiology·Jan Beyer-WestendorfCihan Ay
Feb 9, 2018·Oncoimmunology·Florian PoschThomas Winder
Jan 13, 2019·Current Treatment Options in Oncology·Maria Grazia Ghi, Adriano Paccagnella
Oct 18, 2019·Ear, Nose, & Throat Journal·Michelle PalmieriPaulo H Braz-Silva